000			01393nam a22001937a 4500
005			20250211143654.0
008			250211b ph ||||| |||| 00| 0 eng d
022			_a0279-3695
040			_cOCT
100			_aBiernacki, Pamela
240			_aJournal of Psychosocial Nursing and Mental Health Services / _hMay 2024
245			_aTreatment of anxiety disorders in orimary care : _bWhat nurse practitioners need to know / _cPamela Biernacki and Karan Kverno
300			_aVol 62 (5) pages 7-10 : _billustrations ; _c27 cm
500			_aABSTRACT Anxiety disorders are the most common mental illnesses and frequently co-occur with other mental and somatic symptoms or disorders. Primary care nurse practitioners (NPs) are key in reducing the treatment gap through early identification, treatment, and/ or referral to behavioral health provid-ers. Confronting primary care NPs are problems with time constraints, multiple comorbidities, and limited mental health training, particularly in relation to the differences in pharmacokinetic and pharmacodynamic actions of first-line anxiety disorder medications across age groups. The current article provides a brief summary of evidence-based treatment focusing on pharmacotherapy for anxiety disorders in the primary care setting.
653			_aAnxiety disorders
653			_anon mental illness
700			_aKverno, Karan
942			_2ddc _cCR _n0
999			_c10184 _d10184